Correlation Between Sonnet Biotherapeutics and Hepion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Hepion Pharmaceuticals.

Diversification Opportunities for Sonnet Biotherapeutics and Hepion Pharmaceuticals

0.41

Correlation Coefficient

Sonnet Biotherapeutics  Hepion Pharmaceuticals

Very weak diversification

The 3 months correlation between Sonnet and Hepion is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Hepion Pharmaceuticals

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Hepion Pharmaceuticals. In addition to that, Sonnet Biotherapeutics is 1.26 times more volatile than Hepion Pharmaceuticals. It trades about -0.18 of its total potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest  74.00  in Hepion Pharmaceuticals on September 3, 2024 and sell it today you would lose (7.00) from holding Hepion Pharmaceuticals or give up 9.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Hepion Pharmaceuticals

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sonnet Biotherapeutics and Hepion Pharmaceuticals

The main advantage of trading using opposite Sonnet Biotherapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.

The idea behind Sonnet Biotherapeutics Holdings and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..